Melodiol Global Health Limited (COPHF)
- Previous Close
0.1170 - Open
0.0039 - Bid --
- Ask --
- Day's Range
0.0039 - 0.0039 - 52 Week Range
0.0004 - 9.4660 - Volume
279 - Avg. Volume
5 - Market Cap (intraday)
191,765 - Beta (5Y Monthly) 2.56
- PE Ratio (TTM)
-- - EPS (TTM)
-5.0900 - Earnings Date Aug 29, 2024 - Sep 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
melodiolglobalhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: COPHF
Performance Overview: COPHF
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COPHF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COPHF
Valuation Measures
Market Cap
3.21M
Enterprise Value
9.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.04
Price/Book (mrq)
--
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-277.18%
Return on Assets (ttm)
-33.31%
Return on Equity (ttm)
-389.56%
Revenue (ttm)
18.92M
Net Income Avi to Common (ttm)
-35.52M
Diluted EPS (ttm)
-5.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
692k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
8.37M